Actively Recruiting
Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk
Led by Centre Hospitalier Eure-Seine · Updated on 2025-09-15
50
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn about the feasibility and impact of remote care in patients diagnosed with thromboembolic disease of low risk. The main questions it aims to answer are: * the evaluation of feasibility of organisation between different healthcare professionals (hospital physicians, primary care physician) at 6 months and 1 year * the evaluation of complication rate, hospitalisation related to thromboembolic disease rate, compliance to treatment rate at 6 months and 1 year Participants will receive indication of treatment according to national recommendations. Additionnally, they will receive for the length of study a 4G tablet in order to fill questionnaires, learn information about their drugs (patient education), have a remote consultation and evaluate treatment compliance.
CONDITIONS
Official Title
Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients identified in the emergency department with thromboembolic disease, including deep vein thrombosis or pulmonary embolism with low mortality risk
- Affiliated or beneficiary of social protection
You will not qualify if you...
- Severe obstruction syndrome, ongoing treatment for thromboembolic disease, or suspected heparin-induced thrombocytopenia
- Active hemorrhage or major bleeding risk, severe kidney failure, cancer, or unfavorable medical-social situations
- Caval thrombosis
- Hemorrhagic risk diseases or neurosurgery within the last month, or other surgery within the last 15 days
- Contraindication to direct oral anticoagulants, including certain drug interactions or anti-phospholipid syndrome
- Living in an area without internet coverage
- No primary care physician
- Inability to understand the study due to language or psychological issues, or inability to read or write
- Under legal protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier Eure-Seine
Évreux, France, 27000
Actively Recruiting
Research Team
L
Lydia BEN BEKKOU, ARC
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here